Fortune on Nostr: Some businesses are now backtracking on DEI. Biopharma cannot afford to and must ...
Published at
2024-10-09 11:30:11Event JSON
{
"id": "1558d974a37c26b2c1a3b6209fa3ba5e9177eb078afee581fd13460afb4472bf",
"pubkey": "111599ae9b7352b8fdd1fe2a6a39b3a73116efeaa29e598f3b65511b61d68dbd",
"created_at": 1728473411,
"kind": 1,
"tags": [
[
"guid",
"https://fortune.com/2024/10/09//?preview_id=4034618"
]
],
"content": "Some businesses are now backtracking on DEI. Biopharma cannot afford to and must remain resolute\n\nhttps://fortune.com/img-assets/wp-content/uploads/2024/10/GettyImages-854272762-e1728472901350.jpg?w=2048\n\n'Leaders must hold the line so that never again are medicines developed for and by only some of us,' writes Cytokinetics CEO Robert Blum.\n\nhttps://fortune.com/2024/10/09/businesses-backtracking-dei-biopharma-must-remain-resolute-careers-health-leadership/",
"sig": "7f2e506c1595831a530666cc94627c7353b7dfe07da3443e491a5f066008d02d79eb3ba872a27b5f06ad66dd0adce2886b86385c2fa2fad95ffcd351eb079f89"
}
